Dharancy Sébastien
Maladies de l'appareil digestif, hôpital Claude- Huriez, CHRU de Lille, Lille, France.
Rev Prat. 2018 Sep;68(7):761-765.
When to transplant a patient with alcoholic liver disease? Alcoholic liver disease is the leading cause of cirrhosis in France, but there is only a minority of patients who have access to liver transplantation. Although still controversial, this disease is a validated indication of liver transplantation with survival similar to that of other indications. The survival benefit of transplantation is limited to patients with severe decompensation. A period of abstinence is essential before accessing to the waiting list, but the 6-month abstinence rule is not a strong criterion for predicting the recurrent alcohol consumption after transplantation. In the future, an indication of liver transplantation may be punctually made in case by-case basis in case of steroid-resistant alcoholic hepatitis. The spectrum of post-transplant relapse is a heterogeneous continuum starting with low-level point real consumption, which has little impact on patient and graft survival, up to massive consumption which substantially decreases patient long-term survival. Only a minority of patients experience massive relapse after transplantation. The prevention of relapse need an early addictive specialized management that must begin before the liver transplantation.
何时对酒精性肝病患者进行肝移植?酒精性肝病是法国肝硬化的主要病因,但只有少数患者能够接受肝移植。尽管仍存在争议,但这种疾病是肝移植的有效适应证,其生存率与其他适应证相似。移植的生存获益仅限于严重失代偿患者。在进入等待名单之前,戒酒一段时间至关重要,但6个月戒酒规则并非预测移植后酒精复饮的有力标准。未来,对于类固醇抵抗性酒精性肝炎,可能会逐案适时做出肝移植适应证的判断。移植后复发的情况多种多样,从对患者和移植物生存影响较小的低水平实际饮酒,到大幅降低患者长期生存的大量饮酒。只有少数患者在移植后出现大量复发。预防复发需要在肝移植前就开始早期的专门成瘾管理。